Aminospiropiperidine quinazoline derivatives as selective inhibitors of nitric oxide synthase

Author：  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.1, 2000-01, pp. : 125-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Neuronal Nitric Oxide Synthase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 603-624

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. : 1143-1146

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1207-1210

Informa Healthcare

Access to resources Recommend Favorite

Progress in the Development of Selective Nitric Oxide Synthase (NOS) Inhibitors

By  

Current Pharmaceutical Design, Vol. 8, Iss. 3, 2002-02 ,pp. : 177-200

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Inhibition of Neuronal Nitric Oxide Synthase by L-Arginine Derivatives

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 1, 2008-01 ,pp. : 36-38

Bentham Science Publishers

Access to resources Recommend Favorite